SAMN48146484
External Id
SARS-CoV-2/human/USA/CA-GBW-GKISBBBF48425/2025
External Id
Ginkgo Bioworks
INSDC center name
2025-04-25T00:00:00Z
INSDC first public
2025-04-25T08:59:28.277Z
INSDC last update
SRS24854355
INSDC secondary accession
live
INSDC status
SARS-CoV-2/human/USA/CA-GBW-GKISBBBF48425/2025
Isolate
SARS-CoV-2: clinical or host-associated
NCBI submission model
SARS-CoV-2.cl.1.0
NCBI submission package
SRS24854355
SRA accession
Sri Lanka
add_host_info
Ginkgo Biosecurity
collected_by
2025-04-16
collection_date
2024-10-01
date_of_sars_cov_2_vaccination
USA: California, San Francisco
geo_loc_name
Homo sapiens
host
18-49
host_age
Not Collected [GENEPIO:0001620]
host_disease
female
host_sex
AN swab - individual
isolation_source
Severe acute respiratory syndrome coronavirus 2
http://purl.obolibrary.org/obo/NCBITaxon_2697049
organism
yes - completed
prior_sars_cov_2_vaccination
baseline surveillance (random sampling)
purpose_of_sequencing
SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2
title
not collected
vaccine_received